Ubs Oconnor LLC Moderna, Inc. Call Options Transaction History

Ubs Oconnor LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $63,640 - $125,140	-1,000 Reduced 6.25%	15,000 $1 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $404,840 - $666,440	-4,000 Reduced 20.0%	16,000 $1.9 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $682,960 - $923,520	8,000 Added 66.67%	20,000 $2.13 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $834,120 - $1.25 Million	12,000 New	12,000 $1.19 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $1.42 Million - $2.07 Million	10,500 New	10,500 $1.61 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.